Skip to content
★ Sign in to follow
TC

Thomas C. Lavoy

Perspective Therapeutics, Inc.Alanco Technologies Inc
Total declarations
26
Companies
2
▲ Purchases (11 ops.)
€176k
▼ Sales (3 ops.)
€61k

Latest filing published 02 Mar 2018 for Perspective Therapeutics, Inc., €1,476.

Filing timeline

BuySale
Thomas C. Lavoy

Insider track record

Disclosed buys
11
Disclosed sells
3
Signal history

Closed purchases

Market purchases
11
Positive at T+90
20%
Median T+90
-9.3%

Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Thomas C. Lavoy: trading record in brief

Thomas C. Lavoy discloses dealings in 2 companies, chiefly Alanco Technologies Inc and Perspective Therapeutics, Inc. Over a trading history stretching from 25 April 2007 to 1 March 2018, the count stands at 26 filings.

Market trades split into 11 purchases (€176k) and 3 sales (€61k). Netting one side against the other leaves €116k of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 2 option exercises. So far in 2018, the count stands at 2 purchases and no sales.

The median purchase comes to €11k. Clusters matter here: 3 out of 7 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 10 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 20% of cases, with a median move of -9.3%. These figures describe past trades and do not predict future prices.

The newest entry dates from 2 March 2018: an open-market purchase of €1,476, in Perspective Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Thomas C. Lavoy

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations25 total

25 of 25 declarations